|
Siga Technologies Inc (SIGA) |
|
Siga Technologies Inc
SIGA's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Siga Technologies Inc growth rates, revenue grew
by 271.05 % in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 760
Major Pharmaceutical Preparations industry recorded
growth of revenues by 5.15 %
Siga Technologies Inc realized net income compared to net loss a year ago in II. Quarter 2024
• More on SIGA's Growth
|
|
Siga Technologies Inc current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Siga Technologies Inc PEG ratio is at 0.03
Company is currently trading with Price to Cash flow multiple of 16.83 in trailing twelve-month period. |
Company |
6.13 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.99.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.55.
• More on SIGA's Valuation
|
|
|
|
|
Siga Technologies Inc current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Siga Technologies Inc PEG ratio is at 0.03
Company is currently trading with Price to Cash flow multiple of 16.83 in trailing twelve-month period. |
Company |
6.13 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.99.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.55.
Siga Technologies Inc Price to Book Ratio is at 3.09 lower than Industry Avg. of 82. and higher than S&P 500 Avg. of 0
• More on SIGA's Valuation
|
|
SIGA's Profitability Comparisons
|
Siga Technologies Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in II. Quarter 2024 to 4.95 % from 44.34 % in I. Quarter.
Siga Technologies Inc net profit margin of 8.4 % is currently ranking no. 42 in Major Pharmaceutical Preparations industry, ranking no. 117 in Healthcare sector and number 1481 in S&P 500.
Profitability by Segment |
Total |
8.4 % |
|
|
Siga Technologies Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in II. Quarter 2024 to 4.95 % from 44.34 % in I. Quarter.
Siga Technologies Inc net profit margin of 8.4 % is currently ranking no. 42 in Major Pharmaceutical Preparations industry, ranking no. 117 in Healthcare sector and number 1481 in S&P 500.
• More on SIGA's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com